Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology.
- 1 January 1985
- journal article
- Vol. 63 (3) , 427-44
Abstract
This is the second of two articles summarizing the information currently available on herpes virus diseases. The first described the different members of the herpesvirus group, clinical expression of infection, laboratory diagnosis, and chemotherapy. This article dealing with the epidemiological and immunological aspects of herpesvirus infections also brings up the special problems caused by virus latency and risks associated with congenital infection and immunodeficiency or immunodepressive treatment. The prospects of preventing herpesvirus infections by vaccination and treatment with immune sera are also discussed.This publication has 24 references indexed in Scilit:
- Oral (E)-5-(2-Bromovinyl)-2′-Deoxyuridine treatment of severe herpes zoster in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Prospective study on the relationship between cervical neoplasia and herpes simplex type‐2 virus. I. Epidemiological characteristicsInternational Journal of Cancer, 1984
- Treatment of Herpesvirus InfectionsNew England Journal of Medicine, 1983
- Occupational Risk for Primary Cytomegalovirus Infection among Pediatric Health-Care WorkersNew England Journal of Medicine, 1983
- DNA Restriction-Enzyme Analysis of Herpes Simplex Virus Isolates Obtained from Patients with EncephalitisNew England Journal of Medicine, 1982
- Herpes Simplex Virus Encephalitis: Laboratory Evaluations and Their Diagnostic SignificanceThe Journal of Infectious Diseases, 1982
- Prevalence of antibodies to human cytomegalovirus in Urban, Kibbutz, and bedouin children in southern IsraelJournal of Medical Virology, 1982
- Risk of Recurrence after First Episodes of Genital HerpesNew England Journal of Medicine, 1981
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981
- Elisa for Herpes Simplex Virus (HSV) Type‐Specific Antibodies in Human Sera Using HSV Type 1 and Type 2 Polyspecific Antigens Blocked with Type‐Heterologous Rabbit AntibodiesActa Pathologica Microbiologica Scandinavica Section B Microbiology, 1979